Pfizer

Pfizer

Yahoo Finance • 17 hours ago

Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More

Company Logo Opportunities center on frontline immunotherapy combinations, biomarker and companion diagnostics, AI-enabled pathology, minimally invasive screening, precision therapies for uterine sarcomas, and tele-oncology expansion in u... Full story

Yahoo Finance • yesterday

After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?

Quick Read Pfizer (PFE) yields nearly 7% as COVID drugs crater, while Merck (MRK) compounds at 66% one-year gains with a leaner 3% payout. Pfizer runs 20 pivotal trials in 2026 targeting obesity and oncology, with a Vyndamax patent extens... Full story

Yahoo Finance • 2 days ago

Boomers Should Buy These High-Yield Dividend August Bargains Hand-Over-Fist

Quick Read Five Buy-rated dividend stocks yielding 5% to 7% have dipped on earnings misses or weak guidance, creating compelling entry points for income investors. Altria (MO) and Comcast (CMCSA) yield over 5% each, have pulled back sharp... Full story

Yahoo Finance • 2 days ago

Datadog beats top-line and bottom-line estimates; gives Q3 and updates FY26 outlook

* Datadog press release [https://seekingalpha.com/pr/20609649-datadog-announces-second-quarter-2026-financial-results] (DDOG [https://seekingalpha.com/symbol/DDOG]): Q2 Non-GAAP EPS of $0.65 beats by $0.07. * Revenue of $1.12B (+35.4%... Full story

Yahoo Finance • 2 days ago

Earnings Snapshot: AppLovin Q2 profit climbs 55%, revenue misses; Q3 outlook trails views

[AppLovin Q2 Results 2026: Revenue, EPS, EBITDA and Q3 Outlook] [https://static.seekingalpha.com/uploads/2026/8/5/saupload_apppp.png] MORE ON APPLOVIN * AppLovin Q2 2026 Earnings Preview: The E-Commerce Revenue Engine Is Revving Up [ht... Full story

Yahoo Finance • 2 days ago

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says

After a year at the helm, Novo Nordisk's CEO Maziar Mike Doustdar's task of closing the gap to pacesetter Eli Lilly doesn't look to be getting any easier. Doustdar joined Novo at the height of spiralling erosion to rivals in the obesity a... Full story

Yahoo Finance • 2 days ago

Pfizer Stock Slips Despite Earnings Beat and $2.5 Billion Cuts

This article first appeared on GuruFocus. Pfizer (NYSE:PFE), the pharmaceutical giant behind some of the world's biggest blockbuster drugs, edged about 0.5% lower in Tuesday's early trading despite delivering another earnings beat and rai... Full story

Yahoo Finance • 2 days ago

McDonald's Stock Rises Despite Troubling U.S. Sales Miss

This article first appeared on GuruFocus. McDonald's (NYSE:MCD), the world's largest restaurant chain, ticked higher in Tuesday's trading after delivering another earnings beat, but the real story wasn't profits. It was traffic. Adjusted... Full story

Yahoo Finance • 2 days ago

Health Canada Approves KEYTRUDA® for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after radical cystectomy as adjuvant treatment

KIRKLAND, QC, Aug. 4, 2026 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab for injection), Merck's anti-PD-1 therapy, in combination with enfortumab vedotin,... Full story

Yahoo Finance • 3 days ago

Pfizer Q2 Earnings Call Highlights

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Pfizer (NYSE:PFE) reported second-quarter 2026 revenue of $15 billion and adjusted diluted earnings per share of $0.77, with management saying both measures e... Full story

Yahoo Finance • 3 days ago

Stock Indices Rally on Strong Tech Earnings and US-Iran Peace Hopes

The S&P 500 Index ($SPX) (SPY) today is up +1.13%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.55%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.21%.  September E-mini S&P futures (ESU26) are up +1.20%, and September E-mini... Full story

Yahoo Finance • 3 days ago

Pfizer repels Covid-19 sales tumble to raise 2026 guidance

Pfizer has upgraded the bottom-end of its full-year (FY) revenue outlook by $500m as performance from the drugmaker's lead products more than compensated for weaker Covid-19-related sales. Pfizer now expects 2026 revenue to land between $... Full story

Yahoo Finance • 3 days ago

Merck, Pfizer Lift Full-Year Sales Outlooks Following Second-Quarter Beats

Merck (MRK) and Pfizer (PFE) raised their respective full-year sales outlooks on Tuesday, as both ph PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer raises revenue outlook after quarterly earnings top estimates Proactive uses images sourced from Shutterstock Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoin... Full story

Yahoo Finance • 3 days ago

Why Hims & Hers Is the Perfect Acquisition Target (Even If a Deal Never Happens)

Quick Read HIMS stock has fallen 51% over the past year, yet its 2.6 million subscribers make it a compelling strategic acquisition target. Amazon ranks as the cleanest fit among potential acquirers, with pharmacy customers doubling and i... Full story

Yahoo Finance • 4 days ago

Pfizer Q2 26 Earnings Conference Call At 10:00 AM ET

(RTTNews) - Pfizer Inc. (PFE) will host a conference call at 10:00 AM ET on August 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to http://www.pfizer.com/investors To listen to the call, dial 800-456-4352... Full story

Yahoo Finance • 4 days ago

NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE... Full story

Yahoo Finance • 4 days ago

Pfizer Covid Pill Revenue Plunges 95%. Why Earnings Are Lifting the Stock Anyway.

Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand. Continue Reading... Full story

Yahoo Finance • 4 days ago

Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart Drugs

Sales of Pfizer's Comirnaty Covid vaccine dropped 34% in the quarter. - hannah beier/Reuters Pfizer reported better-than-expected second-quarter results, as rising sales of drugs for cancer and heart disease helped offset steep declines... Full story

Yahoo Finance • 4 days ago

Stocks making the biggest moves premarket: McDonald's, Caterpillar, Palantir, Merck & more

Check out the companies making headlines before the bell: McDonald's — Shares of the hamburger chain gained 1.9% after McDonald's posted earnings of $3.38 per share, on an adjusted basis, compared to the LSEG consensus of $3.32 per share.... Full story